Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.

BMC cancer - 10 Jul 2013

Pataky Reka, Armstrong Linlea, Chia Stephen, Coldman Andrew J, Kim-Sing Charmaine, McGillivray Barbara, Scott Jenna, Wilson Christine M, Peacock Stuart

Abstract excerpt

BACKGROUND: Women with mutations in BRCA1 or BRCA2 are at high risk of developing breast cancer and, in British Columbia, Canada, are offered screening with both magnetic resonance imaging (MRI) and mammography to facilitate early detection. MRI is more sensitive than mammography but is more costly and produces more false positive results. The purpose of this study was to calculate the cost-effectiveness of MRI...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Canada
Share to Cost-Benefit Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Mammography

Share to Markov Chains

Share to Quality-Adjusted Life Years

Source

Open in PubMed Open full text

Identifiers

PMID: 23837641
DOI: 10.1186/1471-2407-13-339
PMCID: PMC3711845

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.PMID 23837641Read ↗

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.Semantic proximity Read ↗

Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.Semantic proximity Read ↗

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.Semantic proximity Read ↗

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers.Semantic proximity Read ↗

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.Semantic proximity Read ↗

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk.Semantic proximity Read ↗

The cost-utility of magnetic resonance imaging for breast cancer in BRCA1 mutation carriers aged 30-49.Semantic proximity Read ↗

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.Semantic proximity Read ↗

Dynamic contrast-enhanced magnetic resonance imaging for risk-stratified screening in women with BRCA mutations or high familial risk for breast cancer: are we there yet?Semantic proximity Read ↗

Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis.Semantic proximity Read ↗

Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.Semantic proximity Read ↗

MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.